X
Safety and Risk of Pharmacotherapy (SRP) is a scholarly journal dedicated to publishing research in the field of Health Professions, and Published by FSBI Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation. The Print-ISSN of Safety and Risk of Pharmacotherapy is 23127821
Safety and Risk of Pharmacotherapy is published by FSBI Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation, based in Russia, publishing since 2015. It covers research in Health Professions, Neuroscience, Pharmacology, Toxicology and Pharmaceutics.
Topics covered include drug safety, undesirable side reactions, signals, risks of pharmacotherapy, pharmacovigilance.
The journal is indexed in Scopus, DOAJ; it uses a double anonymous peer review process.
For full aims and scope, see the journal's official page.
| Journal title | Safety and Risk of Pharmacotherapy (SRP) |
| Print ISSN | 23127821 |
| Online ISSN | 26191164 |
| Publisher Name | FSBI Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation |
| Subject Category | Health Professions |
| Access type | 🟢 Open Access |
| Status | 🟢 Active |
In the context of academic journals, "Metrics and Rankings" refer to various measures and evaluations used to assess the quality, influence, and impact of a journal.
Below are the metrics and rankings for the journal Safety and Risk of Pharmacotherapy
Abstracting and Indexing (A&I) refers to the processes that help organize and categorize academic journals, making them easier to find and access for researchers and scholars
If you would like to submit a manuscript or visit the journal's website, please click on the link below.
| Journal Submission | 🔗 Journal Website |
Add the app to your device for one-tap access.
